What happens when FDA makes an announcement about a possible health issue but really doesn’t have anything to say? FDA’s recent review of AstraZeneca PLC ’s esomeprazole (Nexium) underscores exactly how squeezed the agency is right now.
On August 9, FDA put out a health advisory and scheduled a media call with associate director for safety policy...





